Selene Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Selene Therapeutics General Information

Description

Operator of a therapeutics firm intended to develop a new strategy for treating refractory epilepsy. The company's therapy regulates the neuronal activity set point by reducing the neuronal mean firing rate, enabling healthcare providers to regulate neuronal activity set points and stabilize hyperexcitable hippocampal circuits in patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Ilan Ramon street
  • Ness-Ziona
  • Israel
+972
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • 2 Ilan Ramon street
  • Ness-Ziona
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Selene Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Jun-2024 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Selene Therapeutics’s complete valuation and funding history, request access »

Selene Therapeutics Patents

Selene Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025041128-A1 Brain permeable dhodh inhibitors and uses thereof Inactive 20-Aug-2023

Selene Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selene Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Authority Government Minority
RMGLOBAL Healthcare Fund Management Venture Capital Minority
FutuRx Accelerator/Incubator
To view Selene Therapeutics’s complete investors history, request access »

Selene Therapeutics FAQs

  • When was Selene Therapeutics founded?

    Selene Therapeutics was founded in 2020.

  • Where is Selene Therapeutics headquartered?

    Selene Therapeutics is headquartered in Ness-Ziona, Israel.

  • What is the size of Selene Therapeutics?

    Selene Therapeutics has 3 total employees.

  • What industry is Selene Therapeutics in?

    Selene Therapeutics’s primary industry is Therapeutic Devices.

  • Is Selene Therapeutics a private or public company?

    Selene Therapeutics is a Private company.

  • What is Selene Therapeutics’s current revenue?

    The current revenue for Selene Therapeutics is .

  • Who are Selene Therapeutics’s investors?

    Innovation Authority, RMGLOBAL Healthcare Fund Management, and FutuRx have invested in Selene Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process